Study Evaluating IGSC 20% Flexible Dosing in Treatment-Experienced and Treatment-Naive Subjects With Primary Immunodeficiency
Clinical trial NCT03814798 · WITHDRAWN
Trial details
- NCT number
- NCT03814798
- Sponsor
- Grifols Therapeutics LLC
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-01
- Primary completion
- 2020-09-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.